Longshen Rongfa (300534.SZ): Tongmai oral liquid approved for listing and sale

Zhitan Finance and Economics APP news, Long Shenrong (300534.SZ) announced that its holding subsidiary, Gansu Pu'an Pharmaceutical Co., Ltd., has obtained the "Drug Pre-Market On-Site Verification and First Batch Product Inspection Registration Certificate" issued by the Gansu Provincial Drug Administration. Tongmai Oral Liquid has passed the on-site inspection and technical evaluation of drug production, and the sampled product (batch number: CP022250701) has been tested by the provincial drug testing institute and meets the regulations, and is now available for sale on the market. Tongmai Oral Liquid functions to promote blood circulation, treat ischemic cardiovascular and cerebrovascular diseases, arteriosclerosis, cerebral thrombosis, cerebral ischemia, coronary heart disease, and angina.